(1S,2R,3R,5R)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol结构式
|
常用名 | (1S,2R,3R,5R)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol | 英文名 | (1S,2R,3R,5R)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol |
---|---|---|---|---|
CAS号 | 125073-30-5 | 分子量 | 281.27100 | |
密度 | 2.28g/cm3 | 沸点 | 729ºC at 760 mmHg | |
分子式 | C10H15N7O3 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 394.7ºC |
英文名 | (1S,2R,3R,5R)-3-(5,7-diaminotriazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol |
---|---|
英文别名 | 更多 |
密度 | 2.28g/cm3 |
---|---|
沸点 | 729ºC at 760 mmHg |
分子式 | C10H15N7O3 |
分子量 | 281.27100 |
闪点 | 394.7ºC |
精确质量 | 281.12400 |
PSA | 169.95000 |
蒸汽压 | 2.63E-22mmHg at 25°C |
折射率 | 2.048 |
~53% (1S,2R,3R,5R)-3... 125073-30-5 |
文献:Peterson, Mark L.; Vince, Robert Journal of Medicinal Chemistry, 1990 , vol. 33, # 4 p. 1214 - 1219 |
~% (1S,2R,3R,5R)-3... 125073-30-5 |
文献:Peterson, Mark L.; Vince, Robert Journal of Medicinal Chemistry, 1990 , vol. 33, # 4 p. 1214 - 1219 |
~% (1S,2R,3R,5R)-3... 125073-30-5 |
文献:Peterson, Mark L.; Vince, Robert Journal of Medicinal Chemistry, 1990 , vol. 33, # 4 p. 1214 - 1219 |
~% (1S,2R,3R,5R)-3... 125073-30-5 |
文献:Peterson, Mark L.; Vince, Robert Journal of Medicinal Chemistry, 1990 , vol. 33, # 4 p. 1214 - 1219 |
~% (1S,2R,3R,5R)-3... 125073-30-5 |
文献:Peterson, Mark L.; Vince, Robert Journal of Medicinal Chemistry, 1990 , vol. 33, # 4 p. 1214 - 1219 |
7-Oxabicyclo[4.1.0]hept-3-en-2-ol |
(+/-)-(1S,5S,6R)-5,6-epoxycyclohex-2-en-1-ol |